STOCK TITAN
  1. Home
  2. Sec-filings
  3. EVGN
  4. [6-K] EVOGENE LTD. Current Report (Foreign Issuer)

[6-K] EVOGENE LTD. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock EVGN logo
Evogene

NASDAQ:EVGN

EVGN Rankings

#9702 Ranked by Market Cap
N/A Ranked by Dividends

EVGN Latest News

Jul 8, 2025
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL
Jun 10, 2025
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
May 21, 2025
Evogene Reports First Quarter 2025 Financial Results
May 8, 2025
Evogene Schedules First Quarter 2025 Financial Results Release
Apr 21, 2025
ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio

EVGN Latest SEC Filings

Jul 8, 2025
[6-K] EVOGENE LTD. Current Report (Foreign Issuer)

EVGN Stock Data

12.64M
6.59M
1.56%
7.68%
0.51%
Biotechnology
Healthcare
Link
Israel
Rehovot